Unique Ingredient Identifier 6HG8UB2MUY is listed as a ingredient substance
| RN | 6284-40-8 |
| EC | 228-506-9 |
| NCIT | C61828 |
| RXCUI | 6704 |
| PUBCHEM | 8567 |
| INN ID | 4205 |
| MF | C7H17NO5 |
| INCHI KEY | MBBZMMPHUWSWHV-BDVNFPICSA-N |
| SMILES | CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
UNII 6HG8UB2MUY MEGLUMINE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | INJECTION | 14.48 % |
| INTRAVASCULAR | INJECTION | ADJPH |
| INTRAVENOUS | INJECTION | 15.4 % |
| IV(INFUSION) | INJECTION | 5.7 % |
| ORAL | CAPSULE, DELAYED ACTION | 3.5 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 3.5 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 3 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 5 MG |
| ORAL | TABLET | 24 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 1 MG |
| ORAL | TABLET, DELAYED ACTION | 0.5 MG |
| ORAL | TABLET, FILM COATED | NA |
| URETERAL | SOLUTION | 7.24 % |